大卫·鲁宾斯坦 (David Rubenstein) 加入 Moderna 董事会，接替退休董事斯蒂芬·贝伦森 (Stephen Berenson) 和罗伯特·兰格 (Robert Langer)。 David Rubenstein joins Moderna's Board, replacing retiring directors Stephen Berenson and Robert Langer.

凯雷集团联合创始人兼联席董事长戴维·鲁宾斯坦 (David Rubenstein) 加入 Moderna 董事会，接替即将退休的董事史蒂芬·贝伦森 (Stephen Berenson)。 David Rubenstein, co-founder and co-chairman of The Carlyle Group, joins Moderna's Board of Directors, replacing retiring director Stephen Berenson. 联合创始人兼董事罗伯特·兰格 (Robert Langer) 也将退休，目前正在招募他的继任者。 Co-founder and director Robert Langer is also retiring, with recruitment efforts ongoing for his replacement. 鲁宾斯坦的多行业投资者经验和全球政策专业知识将有助于 Moderna 发展成为一家具有全球影响力的商业公司。 Rubenstein's multi-industry investor experience and global policy expertise will aid Moderna's development as a commercial company with global reach.